Heppe Medical Chitosan GmbH, a Halle, Germany-based innovative developer and producer of pure biopolymers and nanoparticles based on chitin and chitosan, has closed its second financing round with KI Kapital and High-Tech Gründerfonds.
The company produces pure chitin, chitosan und derivates for the cosmetics and pharmaceutical industry under GMP (Good Manufacturing Practice) conditions.
The funds will be used to enlarge the marketing and sales force worldwide. In the coming year, due to the investment, the company can also obtain international quality standard for the production of pharmaceutical ingredients.
The company, which already offers more than 100 different pure chitosans “Made in Germany”, was founded by Katja Heppe following years of studies in biotechnology .